Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study Assessing Safety and Efficacy of PG324 Ophthalmic Solution in Patients With Elevated Intraocular Pressure

This study has been completed.
Information provided by (Responsible Party):
Aerie Pharmaceuticals Identifier:
First received: February 6, 2014
Last updated: January 21, 2016
Last verified: January 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2014
  Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: July 9, 2015